Literature DB >> 11693989

Changes in cellular autophagic capacity during azaserine-initiated pancreatic carcinogenesis.

S Tóth1, K Nagy, Z Palfia, G Réz.   

Abstract

Growth regulation is a crucial event in tumour progression. Surprisingly, relatively few papers have dealt with the catabolic side of regulation, and there are practically no data regarding the autophagic process during tumour development. We approach this problem by morphometrical investigation into the possible changes of autophagic activity during the progression of rat pancreatic adenocarcinoma induced by azaserine. In the present study, autophagic capacity of the azaserine-induced premalignant and malignant cells were characterised and compared to the respective host tissue cells of the rat pancreas and to the acinar cells in other stages of tumour development. Using vinblastine (VBL) as an enhancer, and cycloheximide (CHI) as an inhibitor of autophagic segregation we observed that autophagic capacity of premalignant cells (month 6 and 10 after initiation) is much higher than in the host tissue cells. We found a sharp decrease in self-digesting capacity in adenocarcinoma cells (month 20) where VBL induced a minimal accumulation of autophagic vacuoles which was, surprisingly, not inhibited by CHI, i.e. the CHI-sensitive regulatory step was lost. The changes in autophagic capacity are probably associated to specific steps of tumour progression in our system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11693989     DOI: 10.1556/ABiol.52.2001.4.4

Source DB:  PubMed          Journal:  Acta Biol Hung        ISSN: 0236-5383


  3 in total

1.  Cytoprotective effect of the elongation factor-2 kinase-mediated autophagy in breast cancer cells subjected to growth factor inhibition.

Authors:  Yan Cheng; Huaijun Li; Xingcong Ren; Tingkuang Niu; William N Hait; Jinming Yang
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

2.  Immunohistochemical expression of MAP1LC3A and MAP1LC3B protein in breast carcinoma tissues.

Authors:  Ekhlas Qaid Gazem Othman; Gurjeet Kaur; Ahmad Faisal Mutee; Tengku Sifzizul Tengku Muhammad; Mei Lan Tan
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 3.  Programmed cell death pathways and current antitumor targets.

Authors:  Mei Lan Tan; Jer Ping Ooi; Nawfal Ismail; Ahmed Ismail Hassan Moad; Tengku Sifzizul Tengku Muhammad
Journal:  Pharm Res       Date:  2009-04-30       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.